Jointly provide by Albert Einstein College of Medicine-Montefiore Medical Center and RedMedEd
RME Hot Seat: Prognosis, Treatment Choice, and Risk Management for CLL and MCL
| Overview / Abstract: |
With the emergence of new targeted therapies and new prognostic indicators and goals of treatment, the clinical management of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)—for patients in the frontline and relapsed/refractory settings—has evolved significantly. In this Q&A-based activity, our experts provide practical, evidence-based answers to questions relating to several of the most consequential changes in CLL/MCL patient care, including diagnostic and prognostic risk indicators, novel agents for the frontline and relapsed/refractory setting, and managing adverse events and intolerance. |
|
Expiration |
Apr 20, 2021 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
|
Format |
Online |
|
Credits / Hours |
Albert Einstein College of Medicine-Montefiore Medical Center designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM. |
|
Accreditation |
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and RedMedEd. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
|
Presenters / Authors / Faculty |
Anthony Mato, MD, MSCE—Program Chair John M. Pagel, MD, PhD Chaitra S. Ujjani, MD |
|
Activity Specialities / Related Topics |
Oncology / Cancer / Radiation Therapy, Internal Medicine, Hematology |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by educational grants from AbbVie; Pharmacyclics LLC, an AbbVie Company; and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. |
|
Keywords / Search Terms |
Virtual, Interactive, CME, Free, RedMedEd, Patient case, MCL, CLL, Non Hodgkin lymphoma, B cell lymphoma, Mantle cell lymphoma, Chronic lymphocytic leukemia, Oncology, Hematology, BTK, Bruton tyrosine kinase, Diagnosis, Prognosis, Treatment options, Immunotherapy, Targeted therapy, Oncologist, Hematologist, Advances, Treatment, Cancer, Chemoimmunotherapy, Small lymphocytic lymphoma, Guidelines, Recommendations, Biologic |
|